CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 198 filers reported holding CHEMOCENTRYX INC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $362,000 | -17.9% | 7,000 | -42.1% | 0.00% | 0.0% |
| Q4 2021 | $441,000 | +113.0% | 12,100 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $207,000 | +27.8% | 12,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $162,000 | -72.7% | 12,100 | +4.3% | 0.00% | -66.7% |
| Q1 2021 | $594,000 | -17.3% | 11,600 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $718,000 | +72.6% | 11,600 | +52.6% | 0.00% | +33.3% |
| Q3 2020 | $416,000 | -52.4% | 7,600 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $874,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |